PMID- 33198383 OWN - NLM STAT- MEDLINE DCOM- 20210405 LR - 20210405 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 21 IP - 22 DP - 2020 Nov 12 TI - A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation. LID - 10.3390/ijms21228542 [doi] LID - 8542 AB - Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with no effective treatment. The Hepatocyte Growth Factor/Scatter Factor (HGF/SF), through its receptor MET, is one of the most potent survival-promoting factors for motor neurons (MN) and is known as a modulator of immune cell function. We recently developed a novel recombinant MET agonist optimized for therapy, designated K1K1. K1K1 was ten times more potent than HGF/SF in preventing MN loss in an in vitro model of ALS. Treatments with K1K1 delayed the onset of muscular impairment and reduced MN loss and skeletal muscle denervation of superoxide dismutase 1 G93A (SOD1G93A) mice. This effect was associated with increased levels of phospho-extracellular signal-related kinase (pERK) in the spinal cord and sciatic nerves and the activation of non-myelinating Schwann cells. Moreover, reduced activated microglia and astroglia, lower T cells infiltration and increased interleukin 4 (IL4) levels were found in the lumbar spinal cord of K1K1 treated mice. K1K1 treatment also prevented the infiltration of T cells in skeletal muscle of SOD1G93A mice. All these protective effects were lost on long-term treatment suggesting a mechanism of drug tolerance. These data provide a rational justification for further exploring the long-term loss of K1K1 efficacy in the perspective of providing a potential treatment for ALS. FAU - Vallarola, Antonio AU - Vallarola A AUID- ORCID: 0000-0001-7600-8058 AD - Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - Tortarolo, Massimo AU - Tortarolo M AD - Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - De Gioia, Roberta AU - De Gioia R AD - Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - Iamele, Luisa AU - Iamele L AD - Immunology and General Pathology Unit, Department of Molecular Medicine, Universita di Pavia, 27100 Pavia, Italy. FAU - de Jonge, Hugo AU - de Jonge H AD - Immunology and General Pathology Unit, Department of Molecular Medicine, Universita di Pavia, 27100 Pavia, Italy. FAU - de Nola, Giovanni AU - de Nola G AD - Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA. FAU - Bovio, Enrica AU - Bovio E AUID- ORCID: 0000-0002-7401-5622 AD - Immunology and General Pathology Unit, Department of Molecular Medicine, Universita di Pavia, 27100 Pavia, Italy. FAU - Pasetto, Laura AU - Pasetto L AD - Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - Bonetto, Valentina AU - Bonetto V AD - Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - Freschi, Mattia AU - Freschi M AD - Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - Bendotti, Caterina AU - Bendotti C AUID- ORCID: 0000-0003-1055-1271 AD - Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy. FAU - Gherardi, Ermanno AU - Gherardi E AD - Immunology and General Pathology Unit, Department of Molecular Medicine, Universita di Pavia, 27100 Pavia, Italy. LA - eng GR - SFMET-ALS/AriSLA/ GR - 2015-0023/Regione Lombardia/ PT - Journal Article DEP - 20201112 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (HGF protein, human) RN - 0 (HGF protein, mouse) RN - 0 (Ligands) RN - 207137-56-2 (Interleukin-4) RN - 67256-21-7 (Hepatocyte Growth Factor) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Amyotrophic Lateral Sclerosis/drug therapy/immunology/*metabolism MH - Animals MH - Astrocytes/cytology/metabolism MH - Behavior, Animal MH - Cell Survival MH - Coculture Techniques MH - Disease Models, Animal MH - Disease Progression MH - Dogs MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Gliosis/metabolism MH - Hepatocyte Growth Factor/*agonists MH - Humans MH - *Immune System MH - Interleukin-4/metabolism MH - Kringles MH - Ligands MH - Madin Darby Canine Kidney Cells MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Microglia/metabolism MH - Motor Neurons/metabolism MH - Neurons/*cytology/metabolism MH - Schwann Cells/metabolism MH - Spinal Cord/metabolism MH - T-Lymphocytes/cytology PMC - PMC7696450 OTO - NOTNLM OT - HGF/SF OT - MET OT - SOD1G93A mice OT - T cells OT - amyotrophic lateral sclerosis OT - motor neurons OT - pERK COIS- The authors declare no conflict of interest. EDAT- 2020/11/18 06:00 MHDA- 2021/04/07 06:00 PMCR- 2020/11/01 CRDT- 2020/11/17 01:06 PHST- 2020/10/28 00:00 [received] PHST- 2020/11/09 00:00 [revised] PHST- 2020/11/10 00:00 [accepted] PHST- 2020/11/17 01:06 [entrez] PHST- 2020/11/18 06:00 [pubmed] PHST- 2021/04/07 06:00 [medline] PHST- 2020/11/01 00:00 [pmc-release] AID - ijms21228542 [pii] AID - ijms-21-08542 [pii] AID - 10.3390/ijms21228542 [doi] PST - epublish SO - Int J Mol Sci. 2020 Nov 12;21(22):8542. doi: 10.3390/ijms21228542.